A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation
- PMID: 39367501
- PMCID: PMC11453026
- DOI: 10.1186/s13054-024-05101-z
A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation
Abstract
The optimal dosing strategy of antimicrobial agents in critically ill patients receiving extracorporeal membrane oxygenation (ECMO) is unknown. We conducted comprehensive review of existing literature on effect of ECMO on pharmacokinetics and pharmacodynamics of antimicrobials, including antibacterials, antifungals, and antivirals that are commonly used in critically ill patients. We aim to provide practical guidance to clinicians on empiric dosing strategy for these patients. Finally, we discuss importance of therapeutic drug monitoring, limitations of current literature, and future research directions.
Keywords: Antimicrobial dosing; Extracorporeal membrane oxygenation; Pharmacokinetics; Therapeutic drug monitoring.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
References
-
- Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet. 2003;42(5):403–17. - PubMed
-
- Jaruratanasirikul S, Vattanavanit V, Wongpoowarak W, Nawakitrangsan M, Samaeng M. Pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with extracorporeal membrane oxygenation. Eur J Drug Metab Pharmacokinet. 2020;45(6):735–47. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
